TY - JOUR
T1 - Gender does not influence epsilon-aminocaproic acid concentrations in adults undergoing cardiopulmonary bypass
AU - Butterworth, John
AU - James, Robert L.
AU - Lin, Yonggu A.
AU - Bennett, Judy
AU - Prielipp, Richard C.
PY - 2001
Y1 - 2001
N2 - Epsilon-aminocaproic acid (ε-ACA) is administered to cardiac surgery patients to reduce blood transfusions. Highly water-soluble drugs, such as ε-ACA, often have larger distribution volumes in males than in females. We hypothesized that ε-ACA concentrations using this dosing scheme would differ by gender because of differences in body composition and weight-adjusted volumes of distribution. Ten men and 10 women undergoing elective coronary artery surgery with cardiopulmonary bypass (CPB) received a 50 mg/kg ε-ACA initial dose over 20 min and a 25 mg · kg-1 · h-1 ε-ACA maintenance infusion for 4 h. The area under the ε-ACA arterial concentration versus time curves was compared by using analysis of variance. Measured ε-ACA concentrations were smaller than predicted by the published model, but the area under the concentration versus time curves was not significantly different between men and women. Combining the present concentration data with that previously published, our updated two-compartment model included the following estimated population pharmacokinetic values: V1 (11.8 L pre-CPB, 14.9 L during and after CPB), V2 (12.0 L pre-CPB, 15.0 L during and after CPB), Cl1 (0.125 L/min pre-CPB, 0.037 L/min during CPB, 0.156 L/min after CPB), Cl2 (0.155 L/min pre-CPB, 0.013 L/min during CPB, 0.193 L/min after CPB).
AB - Epsilon-aminocaproic acid (ε-ACA) is administered to cardiac surgery patients to reduce blood transfusions. Highly water-soluble drugs, such as ε-ACA, often have larger distribution volumes in males than in females. We hypothesized that ε-ACA concentrations using this dosing scheme would differ by gender because of differences in body composition and weight-adjusted volumes of distribution. Ten men and 10 women undergoing elective coronary artery surgery with cardiopulmonary bypass (CPB) received a 50 mg/kg ε-ACA initial dose over 20 min and a 25 mg · kg-1 · h-1 ε-ACA maintenance infusion for 4 h. The area under the ε-ACA arterial concentration versus time curves was compared by using analysis of variance. Measured ε-ACA concentrations were smaller than predicted by the published model, but the area under the concentration versus time curves was not significantly different between men and women. Combining the present concentration data with that previously published, our updated two-compartment model included the following estimated population pharmacokinetic values: V1 (11.8 L pre-CPB, 14.9 L during and after CPB), V2 (12.0 L pre-CPB, 15.0 L during and after CPB), Cl1 (0.125 L/min pre-CPB, 0.037 L/min during CPB, 0.156 L/min after CPB), Cl2 (0.155 L/min pre-CPB, 0.013 L/min during CPB, 0.193 L/min after CPB).
UR - http://www.scopus.com/inward/record.url?scp=0034997755&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0034997755&partnerID=8YFLogxK
U2 - 10.1097/00000539-200106000-00005
DO - 10.1097/00000539-200106000-00005
M3 - Article
C2 - 11375809
AN - SCOPUS:0034997755
SN - 0003-2999
VL - 92
SP - 1384
EP - 1390
JO - Anesthesia and Analgesia
JF - Anesthesia and Analgesia
IS - 6
ER -